Tibor Bakacs

Budapest, BU, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Host-targeted oral avian vaccine virus demonstrates broad antiviral activity and safety in patients.

Host-targeted oral avian vaccine virus demonstrates broad antiviral activity and safety in patients.

Journal: Frontiers in immunology
Published: December 03, 2025

Rethinking Immune Checkpoint Inhibition in Cancer.

Rethinking Immune Checkpoint Inhibition in Cancer.

Journal: Scandinavian journal of immunology
Published: November 05, 2025

Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors.

Journal: JCO precision oncology
Published: February 08, 2024

Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.

Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 06, 2023

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections.

Editorial: Fighting fire with fire: Using non-pathogenic viruses to control unrelated infections.

Journal: Frontiers in immunology
Published: September 17, 2022

An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.

An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.

Journal: Cureus
Published: August 27, 2022

Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality.

Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality.

Journal: Cureus
Published: February 28, 2022

Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report.

Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report.

Journal: Cureus
Published: December 09, 2021

A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.

A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.

Journal: Infectious disorders drug targets
Published: November 17, 2021

Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia.

Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia.

Journal: Cureus
Published: May 19, 2021

Tackling cancer cell dormancy: Insights from immune models, and transplantation.

Tackling cancer cell dormancy: Insights from immune models, and transplantation.

Journal: Seminars in cancer biology
Published: October 28, 2020

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution.

Journal: Cancer immunology, immunotherapy : CII
Published: March 08, 2020
Showing 1-12 of 24

Last Updated: 09/26/2026